Squarepoint Ops LLC Surface Oncology, Inc. Transaction History

Squarepoint Ops LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$5.06 - $7.23 $438,433 - $626,457	-86,647 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.57 - $6.56 $114,071 - $476,629	72,657 Added 519.35%	86,647 $568,000
Q1 2020 May 15, 2020	SELL	$1.44 - $3.95 $58,304 - $159,931	-40,489 Reduced 74.32%	13,990 $26,000
Q4 2019 Feb 14, 2020	BUY	$1.17 - $2.33 $63,740 - $126,936	54,479 New	54,479 $102,000
Q3 2019 Nov 14, 2019	SELL	$1.4 - $2.84 $22,856 - $46,365	-16,326 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$2.75 - $4.89 $41,178 - $73,222	-14,974 Reduced 47.84%	16,326 $46,000
Q1 2019 May 15, 2019	SELL	$4.11 - $5.88 $44,379 - $63,492	-10,798 Reduced 25.65%	31,300 $149,000
Q4 2018 Feb 14, 2019	BUY	$3.65 - $10.69 $153,657 - $450,027	42,098 New	42,098 $178,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.